Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Seres Therapeutics (MCRB) Exchange Rate Effect: 2021-2024

  • Seres Therapeutics' Exchange Rate Effect was N/A to -$1,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$1,000, marking a year-over-year change of. This contributed to the annual value of -$1,000 for FY2024, which is 150.00% down from last year.
  • According to the latest figures from Q4 2024, Seres Therapeutics' Exchange Rate Effect is -$1,000, which was down 200.00% from $1,000 recorded in Q3 2023.
  • Seres Therapeutics' Exchange Rate Effect's 5-year high stood at $1,000 during Q4 2022, with a 5-year trough of -$2,000 in Q3 2022.
  • In the last 3 years, Seres Therapeutics' Exchange Rate Effect had a median value of $0 in 2022 and averaged -$250.
  • Data for Seres Therapeutics' Exchange Rate Effect shows a peak YoY skyrocketed of 200.00% (in 2022) over the last 5 years.
  • Over the past 4 years, Seres Therapeutics' Exchange Rate Effect (Quarterly) stood at -$1,000 in 2021, then soared by 200.00% to $1,000 in 2022, then soared by 150.00% to $1,000 in 2023, then reached -$1,000 in 2024.
  • Its last three reported values are -$1,000 in Q4 2024, $1,000 for Q3 2023, and $1,000 during Q4 2022.